Axcelis Technologies, Inc. — FY 2011 Form 10-K
Reporting period: Fiscal year ended December 31, 2011; filed February 29, 2012. This is an annual report, not a standalone fourth-quarter filing. Axcelis designs, manufactures, and services ion implantation, dry strip, and other semiconductor fabrication equipment. Ion implantation accounted for 74.5% of 2011 revenue.
Financial performance
| Metric | FY 2011 | FY 2010 |
|---|---|---|
| Revenue | $319.4 million | $275.2 million |
| Gross profit / margin | $114.7 million / 35.9% | $85.8 million / 31.2% |
| Operating income (loss) / margin | $7.1 million / 2.2% | $(13.4) million / (4.9)% |
| Net income (loss) / diluted EPS | $5.1 million / $0.05 | $(17.6) million / $(0.17) |
| Cash from operating activities | $3.5 million | $(5.9) million |
| Capital expenditures | $2.1 million | $1.4 million |
| Cash and cash equivalents at year-end | $46.9 million | $45.7 million |
| Working capital at year-end | $164.6 million | $160.5 million |
Revenue increased 16.1%. Product revenue was $287.3 million, while service revenue was $32.1 million, slightly below 2010. Product gross margin improved to 36.9% from 30.8%, primarily on product mix and manufacturing productivity; service gross margin fell to 27.0% from 34.3%. Research and development spending rose to $47.2 million from $39.5 million.
Liquidity included $212.0 million in current assets and $47.5 million in current liabilities. The company reported no borrowings and had $23.3 million of available borrowing capacity under its $30 million receivables-based revolving facility. Long-term liabilities were $7.2 million. Operating cash flow less capital expenditures was approximately $1.4 million.
Material changes and operating trends
- Recovery in the semiconductor equipment market lifted full-year revenue and profitability, but conditions weakened in the second half. Quarterly revenue declined from $93.4 million in Q1 2011 to $60.4 million in Q4; Q4 net loss was $2.1 million, versus net income of $4.3 million in Q4 2010.
- Systems backlog, including deferred systems revenue, fell to $23.1 million at year-end from $68.0 million a year earlier. Backlog is cancellable or reschedulable and is not a reliable forecast of subsequent sales.
- Revenue concentration increased: the ten largest customers represented 68.6% of revenue, versus 62.7% in 2010; one customer represented 21.2% of revenue and 27.2% of year-end receivables.
- International revenue was 72.3% of total, compared with 75.8% in 2010. Sales of 300mm equipment represented 75.1% of systems revenue, down from 87.2%.
Outlook, risks, and notable items
- Management expected industry recovery and improved financial results in 2012, based on customer plans and industry conditions, but did not provide quantified revenue or earnings guidance. Planned 2012 capital expenditures were less than $2.5 million.
- In Q1 2012, the company reduced headcount by approximately 9%, expecting annual savings of $8 million to $12 million and termination-related costs of $2.5 million to $3.5 million in Q1 and Q2.
- Key risks include semiconductor-industry cyclicality, delayed customer spending and product penetrations, concentrated customers, competitive and technology-transition pressures, reliance on limited suppliers, international operations, and foreign-exchange exposure. Management cited poor market conditions and prioritization issues as contributing to delays in key product penetrations in H2 2011.
- Systems revenue recognition involves estimates and customer acceptance or installation conditions; $12.3 million of revenue was deferred at year-end. The company adopted new multiple-deliverable revenue guidance in 2011 with no material reported impact.
- Q4 included a $0.9 million tax expense related to an uncertain tax position. The company maintained a full valuation allowance for U.S. deferred tax assets amid cumulative losses; unrecognized tax benefits totaled approximately $8.1 million.
- No impairment charge was recorded after a year-end recoverability test. The company reported no litigation believed likely to have a material adverse effect and no off-balance-sheet arrangements. Auditors issued unqualified opinions on the financial statements and internal control over financial reporting.
Important facts for investors to verify
- Whether the anticipated 2012 industry recovery materialized, and whether new Optima and Integra products gained customer acceptance and generated orders.
- Subsequent backlog, bookings, deferred revenue, and customer shipment or acceptance timing, given the sharp year-end backlog decline.
- Customer concentration and collection exposure, especially the customer comprising 21.2% of revenue and 27.2% of receivables.
- Available revolver capacity, compliance with financial covenants, and cash use if sales weaken.
- Delivery of the announced restructuring savings and the associated 2012 charges.
- Inventory valuation and deferred-tax-asset assumptions, including the impact of any sustained profitability or continued losses.